$SNDK reported Q4 revenue of $8.97B and non-GAAP EPS of $39.25, ahead of consensus. Datacenter revenue reached $2.97B in the quarter.
At the open, $SNDK trades around 13% lower with record Q4 results against a Q1 revenue guide of $10.3B-$10.8B, a midpoint below the $10.8B Street consensus.
→ Revenue: $8.97B vs. $8.24B consensus
→ EPS: $39.25 vs. $33.38 expected (non-GAAP)
→ Q1 guide: $10.3B-$10.8B rev / $44-$46 EPS
FY26 revenue reached $20.25B; five more NBM agreements signed (ten total) with an additional $14B buyback approved.
$SNDK REPORTS Q4 AFTER TODAY'S CLOSE
→ Consensus is $8.24B in revenue and $33.38 non-GAAP EPS expected, versus Q3 revenue of $5.95B and $23.41 non-GAAP EPS
→ Q3 Datacenter revenue was $1.47B and Edge revenue $3.66B; Consumer revenue was $820M
→ Management's Q4 guide was $7.75B-$8.25B in revenue, with 79%-81% non-GAAP gross margin
Focus areas include Datacenter mix, Edge and Consumer trends, NAND pricing and New Business Model backlog growth.
$LLY is up around 4% today with Q2 results reported before the open showing revenue of $22.97B beating the ~$20.6B consensus and adjusted EPS of $8.38 above the $6.58 estimate.
Full-year revenue guidance was raised to $85B-$87B from $82B-$85B, with Mounjaro revenue up 91% to $9.9B and Zepbound at $4.9B.
Adjusted EPS for $LLY included $3.03 in acquired IPR&D charges. A CVS Health partnership brings Zepbound and Foundayo to the CVS app from Q4.
$SPCX FIRST PUBLIC-COMPANY EARNINGS REPORT: REVENUE BEATS, LOSS NARROWER THAN EXPECTED
→ Revenue of $7.81B beat the $6.93B consensus; the adjusted loss of -$0.09 was narrower than the -$0.26 expected.
→ Connectivity (Starlink) revenue rose 66% to $4.29B, with AI revenue up 247% to $2.56B and full-year guidance raised for the first time.
→ Backlog stood at $47.5B, with the quarter ending with roughly $100B in cash.
Traders are weighing the revenue beat against an $18.37B quarter of capex as $SPCX trades down around 10% at the open.
$LLY & $CRCL REPORT Q2 RESULTS BEFORE TOMORROW'S OPEN
→ $LLY: $20.44B revenue / $8.84 adjusted GAAP EPS consensus, with Mounjaro and Zepbound volume, pricing and supply in focus.
→ $CRCL: $734.73M revenue / $0.19 adjusted GAAP EPS consensus, with USDC circulation, reserve yield and distribution costs as key readthroughs.
Novo's raised guide and olomorasib's new FDA designation frame the $LLY setup; $CRCL carries a widening analyst split and roughly $10M of ARK buying.
$AMD & $ALAB REPORT Q2 RESULTS AFTER TODAY'S CLOSE
→ $AMD: consensus is $11.28B in revenue and $1.55 adjusted GAAP EPS, with Data Center, MI450 and Helios timing in focus.
→ $ALAB: consensus is $360.21M in revenue and $0.64 adjusted GAAP EPS, with PCIe 6 demand and Scorpio ramps as key readthroughs.
For $AMD, the main angle is accelerator deployment and Data Center growth; for $ALAB, connectivity and margins.
$TSEM reported record Q2 revenue and profitability, with Q3 revenue guidance at a new company record of $520M ±5%.
On the session, $TSEM is down ~1%, with revenue at $460.08M versus $454.68M consensus and adjusted EPS at $0.88 versus $0.73 expected.
Gross profit reached $138M versus $111M in Q1, while SiPho annual revenue run rate reached $680M versus $180M a year ago.
Into the open, $SPCX is down around 1.8%, with the stock near the bottom of its 52-week range and more than 50% below its June peak.
Short interest is roughly $25B, while Jefferies argues the selloff reflects a broader AI-valuation reset rather than company-specific governance concerns tied to Musk's control.
Trade $SPCX volatility with a Vest Capital funded account and access up to $25k in trading capital.
$IREN is down close to 3% today, with Thursday's sharp rally partially retraced amid broader AI and crypto-linked selling.
About 85% of the more than $4B 2026 AI Cloud ARR target is under contract, with $2.8B in new agreements announced July 20. The $NVDA partnership is part of the pivot to AI cloud.
Convertible debt raises and dilution concerns remain part of the discussion, with shares swinging between roughly $33 and $40 over the past week.
$MU is down around 3.2% on today's session, with sector-wide profit-taking reversing part of Thursday's sharp AI-memory rally.
Situational Awareness unwound its public-stock portfolio amid AI-position losses. Michael Burry expanded his $MU short around $880. Persistent DRAM and NAND shortages remain the fundamental counterpoint.
Trade $MU and broader semiconductor volatility 24/7 with a Vest Capital funded account and access up to $25k in trading capital.
$RIVN Q2 REPORT: R2 DELIVERIES BEGIN
→ Revenue was $1.658B, just above the $1.55B-$1.65B preliminary range; GAAP loss was $0.63 per share vs $0.78 consensus.
→ Gross profit was $179M and adjusted EBITDA -$379M. Deliveries totaled 12,194; external R2 deliveries began June 9.
$RIVN is down close to 8% on the session. The 2026 delivery guide is 65k-70k, with adjusted EBITDA at -$2.0B to -$1.8B and pro forma liquidity at $7.163B.
$RIVN REPORTS Q2 AFTER TODAY'S CLOSE
→ Preliminary revenue is $1.55B-$1.65B; GAAP loss consensus is $0.78 per share.
→ Q2 deliveries reached 12,194 versus a 9,000-11,000 outlook; the guide rose to 65,000-70,000.
→ July's offering sold 86.25M shares at $15.50; quarter-end cash and short-term investments are estimated at ~$5.3B.
$RIVN is roughly flat today, with Piper Sandler's $20 Overweight upgrade in focus. Focus areas include the R2 ramp, automotive gross margin, second-shift timing and capital allocation.
$HOOD REPORTED Q2 YESTERDAY AFTER CLOSE
→ Record revenue rose 32% YoY to $1.31B vs $1.28B consensus; GAAP EPS was $0.62 vs $0.43, including $0.14 from RVI deconsolidation.
→ Transaction revenue rose 44% to $776M: options $342M, equities $129M and event contracts $156M.
→ Crypto revenue fell 38% to $100M; net interest revenue rose 9% to $389M.
Net deposits were $21.7B, platform assets $369B and Gold subscribers 4.8M. Adjusted operating-expense outlook is $2.675B-$2.775B. At the open, $HOOD is up around 1.3%.
$BE is up around 1% on today's session, with record Q2 revenue of $1.065B beating $826.13M consensus and non-GAAP EPS of $0.78 beating $0.41.
Full-year 2026 guidance rose to $3.9B-$4.2B revenue, $2.55-$2.85 non-GAAP EPS and $800M-$900M in non-GAAP operating income.
CEO KR Sridhar cited accelerating demand, with major U.S. hyperscalers and more than 12 AI labs, neoclouds and colocation operators approving Bloom fuel-cell systems.
$MU is down close to 9% today, with China's DRAM buildout and AI-infrastructure financing scrutiny in focus.
Reported domestic Chinese DUV lithography progress adds to the commodity-DRAM supply context. The $MU product mix also includes high-bandwidth memory for AI systems.
South Korea's KOSPI and Japan's Nikkei also moved lower, with regional memory names under pressure.